Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer
Michael Kloth, Vanessa Ruesseler, Christoph Engel, Katharina Koenig, Martin Peifer, Erika Mariotti, Helen Kuenstlinger, Alexandra Florin, Ursula Rommerscheidt-Fuss, Ulrike Koitzsch, Claudia Wodtke, Frank Ueckeroth, Stefanie Holzapfel, Stefan Aretz, Peter Propping, Markus Loeffler, Sabine Merkelbach-Bruse, Margarete Odenthal, Nicolaus Friedrichs, Lukas Carl Heukamp, Thomas Zander, Reinhard Buettner
Gut Aug 2016, 65 (8) 1296-1305; DOI: 10.1136/gutjnl-2014-309026
